IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSIS

ABSTRACT BACKGROUND: The COVID-19 pandemic has overloaded healthcare systems worldwide. Other diseases, such as neoplasms, including gastric cancer, remained prevalent and had their treatment compromised. AIMS: The aim of this study was to evaluate the impact of the COVID-19 pandemic on the treatm...

Full description

Saved in:
Bibliographic Details
Main Authors: Amanda Juliani ARNEIRO, Marina Alessandra PEREIRA, André Roncon DIAS, Ulysses RIBEIRO JUNIOR, Marcus Fernando Kodama Pertille RAMOS
Format: Article
Language:English
Published: Colégio Brasileiro de Cirurgia Digestiva 2025-01-01
Series:ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202024000100343&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542234525827072
author Amanda Juliani ARNEIRO
Marina Alessandra PEREIRA
André Roncon DIAS
Ulysses RIBEIRO JUNIOR
Marcus Fernando Kodama Pertille RAMOS
author_facet Amanda Juliani ARNEIRO
Marina Alessandra PEREIRA
André Roncon DIAS
Ulysses RIBEIRO JUNIOR
Marcus Fernando Kodama Pertille RAMOS
author_sort Amanda Juliani ARNEIRO
collection DOAJ
description ABSTRACT BACKGROUND: The COVID-19 pandemic has overloaded healthcare systems worldwide. Other diseases, such as neoplasms, including gastric cancer, remained prevalent and had their treatment compromised. AIMS: The aim of this study was to evaluate the impact of the COVID-19 pandemic on the treatment of gastric cancer and adherence to the recommended preoperative COVID-19 screening protocol. METHODS: A retrospective study evaluated patients diagnosed with gastric adenocarcinoma who underwent surgical treatment between 2015 and 2023. RESULTS: A total of 769 patients with gastric cancer were evaluated and organized into two groups: (i) pre-COVID group and (ii) COVID group. The pre-COVID group consisted of 527 patients operated on between 2015 and 2019, and the COVID group consisted of 242 patients from 2020 to 2023. The average number of surgical procedures per year in the pre-COVID group was 105 and 81 in the COVID group. There was a statistically significant difference between ASA classification (p=0.002) and clinical staging (p=0.015), which were worse in the COVID group. We observed an increase in diagnostic surgeries (p=0.026), with an increase in the minimally invasive route (p<0.001). In patients undergoing curative surgery, there was a greater indication for postoperative ICU (p=0.022) and neoadjuvant chemotherapy (p<0.001). There was no difference in 30- and 90-day mortality. CONCLUSIONS: The surgical and oncological outcomes for patients operated on during the pandemic remained uncompromised, even though many presented with more advanced initial stages and poorer clinical performance. High adherence to protocols and a low rate of complications related to coronavirus indicate that surgeries were performed safely during this period.
format Article
id doaj-art-46665b75e2d843eba50e9ef37c539287
institution Kabale University
issn 0102-6720
language English
publishDate 2025-01-01
publisher Colégio Brasileiro de Cirurgia Digestiva
record_format Article
series ABCD: Arquivos Brasileiros de Cirurgia Digestiva
spelling doaj-art-46665b75e2d843eba50e9ef37c5392872025-02-04T07:36:29ZengColégio Brasileiro de Cirurgia DigestivaABCD: Arquivos Brasileiros de Cirurgia Digestiva0102-67202025-01-013710.1590/0102-6720202400074e1868IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSISAmanda Juliani ARNEIROhttps://orcid.org/0000-0001-8759-6422Marina Alessandra PEREIRAhttps://orcid.org/0000-0002-6865-0988André Roncon DIAShttps://orcid.org/0000-0003-3378-4916Ulysses RIBEIRO JUNIORhttps://orcid.org/0000-0003-1711-7347Marcus Fernando Kodama Pertille RAMOShttps://orcid.org/0000-0003-0200-7858ABSTRACT BACKGROUND: The COVID-19 pandemic has overloaded healthcare systems worldwide. Other diseases, such as neoplasms, including gastric cancer, remained prevalent and had their treatment compromised. AIMS: The aim of this study was to evaluate the impact of the COVID-19 pandemic on the treatment of gastric cancer and adherence to the recommended preoperative COVID-19 screening protocol. METHODS: A retrospective study evaluated patients diagnosed with gastric adenocarcinoma who underwent surgical treatment between 2015 and 2023. RESULTS: A total of 769 patients with gastric cancer were evaluated and organized into two groups: (i) pre-COVID group and (ii) COVID group. The pre-COVID group consisted of 527 patients operated on between 2015 and 2019, and the COVID group consisted of 242 patients from 2020 to 2023. The average number of surgical procedures per year in the pre-COVID group was 105 and 81 in the COVID group. There was a statistically significant difference between ASA classification (p=0.002) and clinical staging (p=0.015), which were worse in the COVID group. We observed an increase in diagnostic surgeries (p=0.026), with an increase in the minimally invasive route (p<0.001). In patients undergoing curative surgery, there was a greater indication for postoperative ICU (p=0.022) and neoadjuvant chemotherapy (p<0.001). There was no difference in 30- and 90-day mortality. CONCLUSIONS: The surgical and oncological outcomes for patients operated on during the pandemic remained uncompromised, even though many presented with more advanced initial stages and poorer clinical performance. High adherence to protocols and a low rate of complications related to coronavirus indicate that surgeries were performed safely during this period.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202024000100343&lng=en&tlng=enStomach NeoplasmsPandemicsCOVID-19Surgical OncologyGastrectomy
spellingShingle Amanda Juliani ARNEIRO
Marina Alessandra PEREIRA
André Roncon DIAS
Ulysses RIBEIRO JUNIOR
Marcus Fernando Kodama Pertille RAMOS
IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSIS
ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Stomach Neoplasms
Pandemics
COVID-19
Surgical Oncology
Gastrectomy
title IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSIS
title_full IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSIS
title_fullStr IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSIS
title_full_unstemmed IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSIS
title_short IMPACT OF COVID-19 PANDEMIC ON THE SURGICAL TREATMENT OF GASTRIC CANCER: A 3-YEAR ANALYSIS
title_sort impact of covid 19 pandemic on the surgical treatment of gastric cancer a 3 year analysis
topic Stomach Neoplasms
Pandemics
COVID-19
Surgical Oncology
Gastrectomy
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202024000100343&lng=en&tlng=en
work_keys_str_mv AT amandajulianiarneiro impactofcovid19pandemiconthesurgicaltreatmentofgastriccancera3yearanalysis
AT marinaalessandrapereira impactofcovid19pandemiconthesurgicaltreatmentofgastriccancera3yearanalysis
AT andreroncondias impactofcovid19pandemiconthesurgicaltreatmentofgastriccancera3yearanalysis
AT ulyssesribeirojunior impactofcovid19pandemiconthesurgicaltreatmentofgastriccancera3yearanalysis
AT marcusfernandokodamapertilleramos impactofcovid19pandemiconthesurgicaltreatmentofgastriccancera3yearanalysis